Clinical evaluation of weekly 1-hour infusion of paclitaxel in patients with hormone-refractory prostate cancer

被引：0
|
作者：
Hussain, M
机构：
[1] Wayne State Univ, Detroit, MI USA
[2] Karmanos Canc Inst, Detroit, MI USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Weekly 1-hour infusion of paclitaxel -: Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma
    Trivedi, C
    Redman, B
    Flaherty, LE
    Kucuk, O
    Du, W
    Heilbrun, LK
    Hussain, M
    CANCER, 2000, 89 (02) : 431 - 436
  • [2] Weekly 1-hour infusion of paclitaxel: clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma. (vol 89, pg 431, 2000)
    Trivedi, C
    Redman, B
    Flaherty, LE
    Kucuk, O
    Wei, D
    Heilbrun, LK
    CANCER, 2000, 89 (06) : 1412 - 1412
  • [3] WEEKLY ADMINISTRATION OF PACLITAXEL IN HORMONE-REFRACTORY PROSTATE CANCER PATIENTS
    Lombardo, Laura
    Mucciarini, Claudia
    Castagnetti, Giovanni
    Nicolini, Massimiliano
    Maur, Michela
    Frassoldati, Antonio
    Conte, Pier Franco
    ANNALS OF ONCOLOGY, 2004, 15 : 95 - 95
  • [4] Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer
    Chiappino, Isabella
    Destefanis, Paolo
    Addeo, Alfredo
    Galetto, Alessandra
    Cucchiarale, Giuseppina
    Munoz, Fernando
    Zitella, Andrea
    Ferrando, Ugo
    Fontana, Dario
    Ricardi, Umberto
    Tizzani, Alessandro
    Bertetto, Oscar
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 234 - 238
  • [5] Weekly paclitaxel plus estramustine phosphate in hormone-refractory prostate cancer
    Roth, BJ
    Hudes, GR
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 137 - 137
  • [6] Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer
    Chang, AY
    Boros, L
    Asbury, R
    Hui, LF
    Rubins, J
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 69 - 71
  • [7] Weekly docetaxel and estramustine in patients with hormone-refractory prostate cancer
    Copur, MS
    Ledakis, P
    Lynch, J
    Hauke, R
    Tarantolo, S
    Bolton, M
    Norvell, M
    Muhvic, J
    Hake, L
    Wendt, J
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 16 - 21
  • [8] Paclitaxel in the treatment of hormone-refractory prostate cancer
    Smith, DC
    Pienta, KJ
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 109 - 111
  • [9] A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer
    Berry, William
    Friedland, David
    Fleagle, John
    Jackson, Dori
    Ilegbodu, Des
    Boehm, Kristi A.
    Asmar, Lina
    CLINICAL GENITOURINARY CANCER, 2006, 5 (02) : 131 - 137
  • [10] Combination chemotherapy with weekly paclitaxel or docetaxel, carboplatin, and estramustine for hormone-refractory prostate cancer
    Yasufuku, Tomihiko
    Shigemura, Katsumi
    Matsumoto, Osamu
    Arakawa, Soichi
    Fujisawa, Masato
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (03) : 200 - 205
12345